BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10908041)

  • 1. Neuroprotective agent chlomethiazole attenuates c-fos, c-jun, and AP-1 activation through inhibition of p38 MAP kinase.
    Simi A; Ingelman-Sundberg M; Tindberg N
    J Cereb Blood Flow Metab; 2000 Jul; 20(7):1077-88. PubMed ID: 10908041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
    Chun KS; Kim SH; Song YS; Surh YJ
    Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenyl N-tert-butylnitrone down-regulates interleukin-1 beta-stimulated matrix metalloproteinase-13 gene expression in human chondrocytes: suppression of c-Jun NH2-terminal kinase, p38-mitogen-activated protein kinase and activating protein-1.
    Ahmed S; Rahman A; Hasnain A; Goldberg VM; Haqqi TM
    J Pharmacol Exp Ther; 2003 Jun; 305(3):981-8. PubMed ID: 12626640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
    Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
    J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
    Eriksson M; Taskinen M; Leppä S
    J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of lipopolysaccharide-stimulated NO production by a novel synthetic compound CYL-4d in RAW 264.7 macrophages involving the blockade of MEK4/JNK/AP-1 pathway.
    Lin MW; Tsao LT; Chang LC; Chen YL; Huang LJ; Kuo SC; Tzeng CC; Lee MR; Wang JP
    Biochem Pharmacol; 2007 Jun; 73(11):1796-806. PubMed ID: 17379190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation.
    Kwak HJ; Song JS; Heo JY; Yang SD; Nam JY; Cheon HG
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1188-95. PubMed ID: 16126838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells.
    Yu W; Simmons-Menchaca M; You H; Brown P; Birrer MJ; Sanders BG; Kline K
    Mol Carcinog; 1998 Aug; 22(4):247-57. PubMed ID: 9726817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.
    Singh R; Ahmed S; Malemud CJ; Goldberg VM; Haqqi TM
    J Orthop Res; 2003 Jan; 21(1):102-9. PubMed ID: 12507586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of fibroblast collagenase-1 expression by tumor cells of squamous cell carcinomas is mediated by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase-2.
    Westermarck J; Li S; Jaakkola P; Kallunki T; Grénman R; Kähäri VM
    Cancer Res; 2000 Dec; 60(24):7156-62. PubMed ID: 11156425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia.
    Waetzig V; Czeloth K; Hidding U; Mielke K; Kanzow M; Brecht S; Goetz M; Lucius R; Herdegen T; Hanisch UK
    Glia; 2005 May; 50(3):235-46. PubMed ID: 15739188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuroprotective agents chlomethiazole and SB203580 inhibit IL-1beta signalling but not its biosynthesis in rat cortical glial cells.
    Simi A; Porsmyr-Palmertz M; Hjertén A; Ingelman-Sundberg M; Tindberg N
    J Neurochem; 2002 Nov; 83(3):727-37. PubMed ID: 12390534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway.
    Frigo DE; Tang Y; Beckman BS; Scandurro AB; Alam J; Burow ME; McLachlan JA
    Carcinogenesis; 2004 Feb; 25(2):249-61. PubMed ID: 14604893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of MAPKs and NF-kappaB in LPS-induced VCAM-1 expression in human tracheal smooth muscle cells.
    Lin WN; Luo SF; Lee CW; Wang CC; Wang JS; Yang CM
    Cell Signal; 2007 Jun; 19(6):1258-67. PubMed ID: 17303384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Jun does not mediate hepatocyte apoptosis following NFkappaB inhibition and partial hepatectomy.
    Schrum LW; Black D; Iimuro Y; Rippe RA; Brenner DA; Behrns KE
    J Surg Res; 2000 Feb; 88(2):142-9. PubMed ID: 10644480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of c-fos by lipopolysaccharide in glial cells via p38 mitogen-activated protein kinase-dependent activation of serum or cyclic AMP/calcium response element.
    Simi A; Edling Y; Ingelman-Sundberg M; Tindberg N
    J Neurochem; 2005 Feb; 92(4):915-24. PubMed ID: 15686494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
    Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
    Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.